Biotech Updates

Limagrain Obtains License for I-Sce1 meganuclease Technology

June 5, 2009

Limagrain, an international cooperative group based in France signed a non-exclusive license agreement for the use of the I-SceI meganuclease for use in plants from Cellectis. This will allow Limagrain to conduct research and development of important plant traits using biotechnology. Biogemma, a biotechnology company with Limagrain stocks, will  be responsible for the production of the plants. Subsequently, the plants will be commercialized by Limagrain and other shareholders of Biogemma. The agreement complements the thrusts of the involved partners to develop genetically modified plants that would allow the assembly of multiple traits of interest in a single plant.

For details, see press release at: http://www.cellectis.com/fileadmin/Cellectis/Communiques_de_Presse/clspr-gb-090602.pdf